Palisade Bio, Inc. announced on September 26, 2025, that its special meeting of stockholders was again adjourned due to a lack of the required quorum. This marks the second time the meeting has been postponed, indicating ongoing challenges in securing sufficient shareholder votes.
At the time of the adjournment, proxies had been submitted by stockholders representing approximately 29.68% of the outstanding shares, which is below the one-third quorum requirement. The meeting was adjourned to allow more time for stockholders to vote on the proposals.
The special meeting is now scheduled to reconvene on Friday, October 10, 2025. The company continues to solicit votes and has engaged a proxy solicitor to assist in obtaining the necessary quorum, incurring additional costs due to these delays.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.